JENNIFER GREEN: Open Payments
NPI 1003478801 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 67 payments from 21 companies in 2025. Trend: 2023 $397 · 2024 $1,619 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 12 | $165 |
| Xeris Pharmaceuticals, Inc. | 9 | $153 |
| Amgen Inc. | 6 | $118 |
| CeQur Corporation | 1 | $116 |
| Lilly USA, LLC | 6 | $106 |
| Sequel Med Tech, LLC | 3 | $74 |
| ABBVIE INC. | 4 | $67 |
| Tandem Diabetes Care, Inc. | 3 | $62 |
| BETA BIONICS, INC. | 3 | $62 |
| Ascensia Diabetes Care Us Inc. | 2 | $43 |
Products named: TZIELD, CeQur Simplicity, MOUNJARO, RECORLEV, EVENITY, TWIIST, GVOKE HYPOPEN, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across UT — which companies pay providers there.
